Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients.
CONCLUSIONS Beta-blocker and statin combination therapy lowered the risk of developing MACE in ACS patients.
PMID: 32808600 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Beta-Blockers | Biomedical Science | Cardiology | Cardiovascular | Cholesterol | Heart | Research | Science | Statin Therapy